Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

May 31, 2010

Conditions
Prostate Cancer
Interventions
DRUG

docetaxel

35 mg/m2 i.v. over 15 - 30 minutes will be administered immediately after the mitoxantrone on the same schedule.

DRUG

mitoxantrone hydrochloride

Initial dose will be 2 mg/m2 weekly for 3 of every 4 weeks. The dose will then be escalated as described in the dose escalation section up to a maximum dose of 6 mg/m2 weekly for 3 of every 4 weeks.

PROCEDURE

conventional surgery

Prostatectomy will be scheduled 2 - 4 weeks after the last dose of chemotherapy.

Trial Locations (2)

97239

Portland VA Medical Center, Portland

97239-3098

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT00017563 - Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer | Biotech Hunter | Biotech Hunter